For Pharmacotherapeutics For Advanced Practice: A Practical Approach 5th
Edition, By Virginia Poole Arcangelo
Questions And Answers Graded A+
Printend Pdf|Original Direct From Publisher|100% Verified
Answers|Dowload Immediately After The Order
5th edition
complete test bank, all chapter are included
for more documents search (testbankproferssor.stuvia
, TABLE OF CONTENTS
chapter 1 issues for the practitioner in drug therapy ...................................................................................... 4
chapter 2. pharmacokinetic basis of therapeutics andpharmacodynamic....................................................... 5
chapter 3. impact of drug interactions and adverse events ontherapeutics .................................................. 10
chapter 4. principles of pharmacotherapy in children .................................................................................. 14
chapter 5. principles of pharmacotherapy in pregnancy and ....................................................................... 15
chapter 6. principles of pharmacotherapy in elderly patients ...................................................................... 20
chapter 7 principles of pharmacotherapy in pain ......................................................................................... 21
chapter 8. principles of antimicrobial therapy ............................................................................................. 25
chapter 9. complementary and alternative medicines .................................................................................. 28
chapter 10. pharmacogenomics.................................................................................................................... 30
chapter 11. contact dermatitis .................................................................................................................... 33
chapter 12. fungal infections of the skin ...................................................................................................... 35
chapter 13 viral infections of the skin.......................................................................................................... 37
chapter 14 bacterial infections of the skin ................................................................................................... 38
chapter 15. psoriasis..................................................................................................................................... 42
chapter 16. acne vulgaris and rosacea ......................................................................................................... 43
chapter 17 ophthalmic disorders .................................................................................................................. 44
chapter 18 ophthlamic disorders .................................................................................................................. 47
chapter 19. hypertension .............................................................................................................................. 50
chapter 20. hyperlipidemia........................................................................................................................... 53
chapter 21. angina ...................................................................................................................................... 56
chapter 22. heart failure ............................................................................................................................... 60
chapter 23. dysrhythmias ............................................................................................................................. 62
chapter 24 upper respiratory infections ....................................................................................................... 65
chapter 25. asthma ..................................................................................................................................... 67
chapter 26. chronic obstructive pulmonary disease ..................................................................................... 69
chapter 27. bronchitis and pneumonia ......................................................................................................... 70
chapter 28. nausea and vomiting .............................................................................................................. 71
chapter 29. gastroesophageal reflux disease and peptic ulcer disease ......................................................... 73
chapter 30. constipation diarrhea and irritable bowel syndrome ................................................................. 75
chapter 31 inflammatory bowel disease ...................................................................................................... 77
chapter 32. urinary tract infections .............................................................................................................. 78
chapter 34. overactive bladder ..................................................................................................................... 80
chapter 35. sexually transmitted infections ................................................................................................. 82
chapter 36. osteoarthritis and rheumatoid arthritis ...................................................................................... 84
chapter 37. fibromyalgia .............................................................................................................................. 86
ch 38. headaches .......................................................................................................................................... 87
chapter 39 seizure disorders......................................................................................................................... 90
,chapter 40. depressive disorders .................................................................................................................. 92
chapter 41. depressive disorders .................................................................................................................. 94
chapter 42 insomnia and sleep disorders ..................................................................................................... 96
chapter 43. attention deficit/hyperactivity disorder ..................................................................................... 97
chapter 44. alzheimer’s disease .................................................................................................................. 98
chapter 45. diabetes mellitus ....................................................................................................................... 99
chapter 46. thyroid disorders ..................................................................................................................... 104
chapter 47. allergies and allergic reactions ................................................................................................ 107
chapter 48. human immunodeficiency virus .............................................................................................. 109
chapter 49. coagulation disturbances ......................................................................................................... 112
chapter 50. anemias .................................................................................................................................. 113
chapter 51. immunizations chapter 53. travel medications ........................................................................ 116
chapter 52. smoking cessation ................................................................................................................... 119
chapter 54. weight loss .............................................................................................................................. 121
chapter 55. contraception ........................................................................................................................... 123
chapter 56. menopause and menopausal hormone therapy ........................................................................ 125
chapter 57. osteoporosis............................................................................................................................. 126
chapter 58 vaginitis .................................................................................................................................... 128
chapter 59. the economics of pharmacotherapeutics.................................................................................. 129
chapter 60. integrative approaches to pharmacotherapy – a look atcomplex cases .................................. 132
, Chapter 1 Issues For The Practitioner In Drug Therapy
Multiple Choice
1. Nurse Practitioner Prescriptive Authority Is Regulated By:
A. The National Council Of State Boards Of
Nursing
B. The U.S. Drug Enforcement Administration
C. The State Board Of Nursing For Each State
D. The State Board Of Pharmacy
Ans: C Pts: 1
2. Physician Assistant (Pa) Prescriptive Authority Is Regulated By:
A. The National Council Of State Boards Of
Nursing
B. The U.S. Drug Enforcement Administration
C. The State Board Of Nursing
D. The State Board Of Medical Examiners
Ans: D Pts: 1
3. Clinical Judgment In Prescribing Includes:
A. Factoring In The Cost To The Patient Of The Medication Prescribed
B. Always Prescribing The Newest Medication Available For The Disease
Process
C. Handing Out Drug Samples To Poor Patients
D. Prescribing All Generic Medications To Cut Costs
Ans: A Pts: 1
4. Criteria For Choosing An Effective Drug For A Disorder Include:
A. Asking The Patient What Drug They Think Would Work Best For Them
B. Consulting Nationally Recognized Guidelines For Disease Management
C. Prescribing Medications That Are Available As Samples Before Writing A
Prescription
D. Following U.S. Drug Enforcement Administration (Dea) Guidelines For
Prescribing
Ans: B Pts: 1
5. Nurse Practitioner Practice May Thrive Under Health-Care Reform Due To:
A. The Demonstrated Ability Of Nurse Practitioners To Control Costs And Improve
Patient Outcomes
B. The Fact That Nurse Practitioners Will Be Able To Practice Independently
C. The Fact That Nurse Practitioners Will Have Full Reimbursement Under Health-
Care Reform
D. The Ability To Shift Accountability For Medicaid To The State Level
Ans: A Pts: 1
Edition, By Virginia Poole Arcangelo
Questions And Answers Graded A+
Printend Pdf|Original Direct From Publisher|100% Verified
Answers|Dowload Immediately After The Order
5th edition
complete test bank, all chapter are included
for more documents search (testbankproferssor.stuvia
, TABLE OF CONTENTS
chapter 1 issues for the practitioner in drug therapy ...................................................................................... 4
chapter 2. pharmacokinetic basis of therapeutics andpharmacodynamic....................................................... 5
chapter 3. impact of drug interactions and adverse events ontherapeutics .................................................. 10
chapter 4. principles of pharmacotherapy in children .................................................................................. 14
chapter 5. principles of pharmacotherapy in pregnancy and ....................................................................... 15
chapter 6. principles of pharmacotherapy in elderly patients ...................................................................... 20
chapter 7 principles of pharmacotherapy in pain ......................................................................................... 21
chapter 8. principles of antimicrobial therapy ............................................................................................. 25
chapter 9. complementary and alternative medicines .................................................................................. 28
chapter 10. pharmacogenomics.................................................................................................................... 30
chapter 11. contact dermatitis .................................................................................................................... 33
chapter 12. fungal infections of the skin ...................................................................................................... 35
chapter 13 viral infections of the skin.......................................................................................................... 37
chapter 14 bacterial infections of the skin ................................................................................................... 38
chapter 15. psoriasis..................................................................................................................................... 42
chapter 16. acne vulgaris and rosacea ......................................................................................................... 43
chapter 17 ophthalmic disorders .................................................................................................................. 44
chapter 18 ophthlamic disorders .................................................................................................................. 47
chapter 19. hypertension .............................................................................................................................. 50
chapter 20. hyperlipidemia........................................................................................................................... 53
chapter 21. angina ...................................................................................................................................... 56
chapter 22. heart failure ............................................................................................................................... 60
chapter 23. dysrhythmias ............................................................................................................................. 62
chapter 24 upper respiratory infections ....................................................................................................... 65
chapter 25. asthma ..................................................................................................................................... 67
chapter 26. chronic obstructive pulmonary disease ..................................................................................... 69
chapter 27. bronchitis and pneumonia ......................................................................................................... 70
chapter 28. nausea and vomiting .............................................................................................................. 71
chapter 29. gastroesophageal reflux disease and peptic ulcer disease ......................................................... 73
chapter 30. constipation diarrhea and irritable bowel syndrome ................................................................. 75
chapter 31 inflammatory bowel disease ...................................................................................................... 77
chapter 32. urinary tract infections .............................................................................................................. 78
chapter 34. overactive bladder ..................................................................................................................... 80
chapter 35. sexually transmitted infections ................................................................................................. 82
chapter 36. osteoarthritis and rheumatoid arthritis ...................................................................................... 84
chapter 37. fibromyalgia .............................................................................................................................. 86
ch 38. headaches .......................................................................................................................................... 87
chapter 39 seizure disorders......................................................................................................................... 90
,chapter 40. depressive disorders .................................................................................................................. 92
chapter 41. depressive disorders .................................................................................................................. 94
chapter 42 insomnia and sleep disorders ..................................................................................................... 96
chapter 43. attention deficit/hyperactivity disorder ..................................................................................... 97
chapter 44. alzheimer’s disease .................................................................................................................. 98
chapter 45. diabetes mellitus ....................................................................................................................... 99
chapter 46. thyroid disorders ..................................................................................................................... 104
chapter 47. allergies and allergic reactions ................................................................................................ 107
chapter 48. human immunodeficiency virus .............................................................................................. 109
chapter 49. coagulation disturbances ......................................................................................................... 112
chapter 50. anemias .................................................................................................................................. 113
chapter 51. immunizations chapter 53. travel medications ........................................................................ 116
chapter 52. smoking cessation ................................................................................................................... 119
chapter 54. weight loss .............................................................................................................................. 121
chapter 55. contraception ........................................................................................................................... 123
chapter 56. menopause and menopausal hormone therapy ........................................................................ 125
chapter 57. osteoporosis............................................................................................................................. 126
chapter 58 vaginitis .................................................................................................................................... 128
chapter 59. the economics of pharmacotherapeutics.................................................................................. 129
chapter 60. integrative approaches to pharmacotherapy – a look atcomplex cases .................................. 132
, Chapter 1 Issues For The Practitioner In Drug Therapy
Multiple Choice
1. Nurse Practitioner Prescriptive Authority Is Regulated By:
A. The National Council Of State Boards Of
Nursing
B. The U.S. Drug Enforcement Administration
C. The State Board Of Nursing For Each State
D. The State Board Of Pharmacy
Ans: C Pts: 1
2. Physician Assistant (Pa) Prescriptive Authority Is Regulated By:
A. The National Council Of State Boards Of
Nursing
B. The U.S. Drug Enforcement Administration
C. The State Board Of Nursing
D. The State Board Of Medical Examiners
Ans: D Pts: 1
3. Clinical Judgment In Prescribing Includes:
A. Factoring In The Cost To The Patient Of The Medication Prescribed
B. Always Prescribing The Newest Medication Available For The Disease
Process
C. Handing Out Drug Samples To Poor Patients
D. Prescribing All Generic Medications To Cut Costs
Ans: A Pts: 1
4. Criteria For Choosing An Effective Drug For A Disorder Include:
A. Asking The Patient What Drug They Think Would Work Best For Them
B. Consulting Nationally Recognized Guidelines For Disease Management
C. Prescribing Medications That Are Available As Samples Before Writing A
Prescription
D. Following U.S. Drug Enforcement Administration (Dea) Guidelines For
Prescribing
Ans: B Pts: 1
5. Nurse Practitioner Practice May Thrive Under Health-Care Reform Due To:
A. The Demonstrated Ability Of Nurse Practitioners To Control Costs And Improve
Patient Outcomes
B. The Fact That Nurse Practitioners Will Be Able To Practice Independently
C. The Fact That Nurse Practitioners Will Have Full Reimbursement Under Health-
Care Reform
D. The Ability To Shift Accountability For Medicaid To The State Level
Ans: A Pts: 1
